Lifeward Ltd. (LFWD)
NASDAQ: LFWD · Real-Time Price · USD
1.385
+0.015 (1.09%)
May 12, 2025, 2:14 PM - Market open
Lifeward Revenue
In the year 2024, Lifeward had annual revenue of $25.66M with 85.24% growth. Lifeward had revenue of $7.55M in the quarter ending December 31, 2024, with 9.60% growth.
Revenue (ttm)
$25.66M
Revenue Growth
+85.24%
P/S Ratio
0.46
Revenue / Employee
$320,788
Employees
80
Market Cap
14.72M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 25.66M | 11.81M | 85.24% |
| Dec 31, 2023 | 13.85M | 8.34M | 151.39% |
| Dec 31, 2022 | 5.51M | -455.00K | -7.63% |
| Dec 31, 2021 | 5.97M | 1.57M | 35.81% |
| Dec 31, 2020 | 4.39M | -480.00K | -9.85% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
LFWD News
- 4 days ago - Lifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and Exoskeletons - GlobeNewsWire
- 4 days ago - Lifeward to Report First Quarter 2025 Financial Results on May 15, 2025 - GlobeNewsWire
- 13 days ago - First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton - GlobeNewsWire
- 18 days ago - Paralyzed Israeli Soldier Walks Again with Use of the ReWalk Personal Exoskeleton - GlobeNewsWire
- 27 days ago - Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market - GlobeNewsWire
- 2 months ago - FDA Issues Clearance for ReWalk 7 Exoskeleton - GlobeNewsWire
- 2 months ago - Lifeward Ltd. (LFWD) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Lifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire